Valvular & structural heart diseaseMeta-analysis

Mechanical versus biological aortic valve replacement in patients aged 50–70 years: a systematic review and meta-analysis

HeartPublished

  • systematic review and meta-analysis of randomised and observational studies
  • inverse variance random-effects meta-analysis

Authors' conclusion

Drawing largely from observational data, mechanical valves were associated with superior overall survival but increased bleeding due to lifelong anticoagulation. Bioprosthetic valves offer lower bleeding risk but higher reoperation rates from structural degeneration. The growing use of bioprosthetic valves in this age group may lead to more reinterventions in older, more comorbid patients. Contemporary randomised trials are needed to evaluate outcomes with modern valve designs.

Study context

Population
Patients aged 50–70 years undergoing mechanical or bioprosthetic aortic valve replacement (AVR)30 studies, 29 of which were observational
Participants
120,844 patients
Comparison
mechanical and bioprosthetic AVR
Outcome
Overall survival

Pooled result

As reported in the abstract

Hazard ratio

0.88

95% CI 0.81–0.94

P = 0.001

Mechanical valves vs Bioprosthetic valves
HR 0.88 (95% CI 0.81–0.94); P = 0.001

Further pooled results

OutcomeHR (95% CI)P value
Stroke · did not differ significantly · secondary outcome1.07 (0.91–1.27)P = 0.37
Reoperation · bioprosthetic valves had higher reoperation rates · secondary outcome0.44 (0.33–0.57)P < 0.001

Safety

OutcomeHR (95% CI)P value
Major bleeding · higher risk with mechanical valves · secondary outcome1.60 (1.43–1.78)P < 0.001

Original publication

Mechanical versus biological aortic valve replacement in patients aged 50–70 years: a systematic review and meta-analysis. Heart. Published 18 March 2026. doi:10.1136/heartjnl-2025-327763

Summarised from the published abstract; every number is checked against it